Liver-Directed Locoregional Therapies for Neuroendocrine Liver Metastases: Recent Advances and Management
CR Criss, MS Makary - Current Oncology, 2024 - mdpi.com
Neuroendocrine tumors (NETs) are a heterogeneous class of cancers, predominately
occurring in the gastroenteropancreatic system, which pose a growing health concern with a …
occurring in the gastroenteropancreatic system, which pose a growing health concern with a …
Current Management of Neuroendocrine Tumour Liver Metastases
A Sharma, M Muralitharan, J Ramage… - Current Oncology …, 2024 - Springer
Purpose of review This article aims to illustrate the current state of investigations and
management of liver metastases in patients with Neuroendocrine Neoplasms …
management of liver metastases in patients with Neuroendocrine Neoplasms …
[HTML][HTML] Liver Resection for Gastroenteropancreatic Neuroendocrine Tumors with Extrahepatic Disease
KM Mahuron, KE Limbach, MC Hernandez… - Journal of Clinical …, 2024 - mdpi.com
Background: Although survival outcomes for neuroendocrine liver metastases (NETLM) are
improved with liver-direct therapies (LDT), including hepatic debulking and nonsurgical …
improved with liver-direct therapies (LDT), including hepatic debulking and nonsurgical …
Radioembolisation mit Harz-und Glas-Mikrosphären
H Ilhan, L Stegger, H Ahmadzadehfar - Radiopraxis, 2024 - thieme-connect.com
Die transarterielle Radioembolisation (TARE) ist eine lokal ablative Therapieoption bei
primären und sekundären Lebertumoren mit leberdominanter Erkrankung. Dieser Artikel …
primären und sekundären Lebertumoren mit leberdominanter Erkrankung. Dieser Artikel …
Radioembolisation mit Harz-und Glas-Mikrosphären
H Ilhan, L Stegger… - Angewandte …, 2023 - thieme-connect.com
Transarterial radioembolization (TARE) or synonymously used selective internal
radiotherapy (SIRT) is a local ablative therapy option for primary and secondary liver tumors …
radiotherapy (SIRT) is a local ablative therapy option for primary and secondary liver tumors …